Rosen Law Firm Invites Unicycive Therapeutics Investors to Lead Securities Fraud Lawsuit

Rosen Law Firm, an international investor rights law firm, has issued a notice reminding purchasers of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) securities to consider participating in a class action lawsuit concerning alleged securities fraud. The firm highlighted an important deadline of November 2, 2026, for individuals seeking to serve as lead plaintiff.

The lawsuit targets investors who acquired Unicycive securities during the "Class Period," defined as December 29, 2025, through June 29, 2026. The firm states that eligible investors may be entitled to compensation without incurring out-of-pocket expenses, operating under a contingency fee arrangement.

According to the allegations within the lawsuit, Unicycive Therapeutics made materially false and misleading statements and failed to disclose crucial information during the Class Period. Specifically, the company allegedly did not properly inspect its third-party manufacturing vendor's facility or audit its compliance with current good manufacturing practices (cGMP). Consequently, Unicycive allegedly lacked a reasonable basis to believe the vendor had resolved deficiencies previously cited by the U.S. Food and Drug Administration (FDA).

The complaint further alleges that this failure created an undisclosed risk that the FDA would require additional information regarding the vendor's manufacturing practices. This, in turn, created a likelihood of delay in the regulatory approval of oxylanthanum carbonate (OLC). The lawsuit claims that as a result, defendants' positive statements about Unicycive's business, operations, and prospects were misleading and lacked a reasonable basis, leading to investor damages when the true facts emerged.

It is important to note that no class has yet been certified in the action. Investors are not represented by counsel unless they retain their own. They may also choose to remain an absent class member. Serving as lead plaintiff is not a prerequisite for sharing in any potential future recovery.